PG
Pharming Group NV
🇳🇱XAMS.PHARMNetherlandsHealthcare
€0.92EURup +0.01 (+1.1%)ClosedEnd of day5:41 PM
Price€0.92+0.01 (+1.1%)
Profile
- Healthcare
- Biotechnology
- Netherlands
Identity
- Exchange
- Euronext Amsterdam . XAMS
- Type
- Stock
- ISIN
- NL0010391025
- CUSIP
- Not reported
Company
- Employees
- 407
- Headquarters
- Leiden, United States
- Website
- https://www.pharming.com
- CEO
- Mr. Fabrice Chouraqui M.B.A., Ph.D., Pharm.D.
Market
- Shares outstanding
- 685.1M
- Market cap
- €630.34M
Highlights
- Market cap
- €623.48M
- EPS LTM
- $0.01calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- Not reported
- Div yield
- 0%
Fundamentals (LTM)
- Revenue
- $366.45M-99.61%down year on year
- Net income
- $9.27M-99.68%down year on year
- Gross margin
- 86.53%-0.37%down year on year
- Free cash flow
- $31.34M+4.03%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.